Tuesday, November 6, 2018

The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.


from Reuters: Health News https://ift.tt/2Orwcd2

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Most elderly patients taking multiple prescription medications would be willing to reduce their daily pill regimen to minimize their risk of side effects like falls or dangerous drug interactions, a U.S. st… Read More
  • LATEST HEALTH NEWSHow preferential allotment of organs to foreigners and the well-off is undermining trust in the process of organ donation from Health https://ift.tt/2OsxHwk … Read More
  • LATEST HEALTH NEWSExercise at least 45 minutes every day - brisk walking, running, cycling or any other form of physical activity is beneficial from Health https://ift.tt/2ITMUAz … Read More
  • LATEST HEALTH NEWSOf the tainted products in the current study, 45.5% were marketed as aids for sexual enhancement, 40.9% for weight loss from Health https://ift.tt/2Or2ucU … Read More
  • LATEST HEALTH NEWS(Reuters Health) - While age-related hearing loss has long been linked to cognitive decline, a UK study suggests hearing aids may help minimize the risk of problems like impaired memory or executive function. from Reuter… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner